In addition to our study, other deep profiling methods to evaluate TIL subtypes and cellular markers associated with therapy response in TNBC have included multiplex imaging (42), bioinformatic deconvolution of bulk public mRNA data (43, 44), and RNAseq of tumours stratified by CD8+ TIL abundance (45, 46). This evidence concerns the gene CD8A and neoplasm.